The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

Matthew H. Liang, Peter H. Schur, Paul Fortin, E. William St.Clair, James E. Balow, Karen Costenbader, Leslie Crofford, Paola De Pablo, Mary Anne Dooley, Axel Finckh, Caroline P. Gordon, Ingrid E. Lundberg, Alain Meyrier, Ola Nived, Claudio Ponticelli, Matthias K. Schneider, Ajay Singh, Daniel J. Wallace

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)421-432
Number of pages12
JournalArthritis and Rheumatism
Volume54
Issue number2
DOIs
Publication statusPublished - Feb 2006

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Liang, M. H., Schur, P. H., Fortin, P., St.Clair, E. W., Balow, J. E., Costenbader, K., Crofford, L., De Pablo, P., Dooley, M. A., Finckh, A., Gordon, C. P., Lundberg, I. E., Meyrier, A., Nived, O., Ponticelli, C., Schneider, M. K., Singh, A., & Wallace, D. J. (2006). The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis and Rheumatism, 54(2), 421-432. https://doi.org/10.1002/art.21625